Sign in

CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453215903
Phone
(508) 767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
Open-market buys, last 90 days
$104,806
in 9 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 55 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-09 Plott Ronald Todd Director Purchase +18,300 $0.83 $15K 60,300
2026-09-29 Plott Ronald Todd Director Purchase +5,000 $1.04 $5K 42,000
2026-09-28 Plott Ronald Todd Director Purchase +5,000 $1.03 $5K 37,000
2026-09-28 Plott Ronald Todd Director Grant or award +17,000 32,000
2026-08-19 Plott Ronald Todd Director Purchase +15,000 $1.14 $17K 15,000

Page 1 of 1 · 5 trades